Comparing a Single-Dose vs. Twice Yearly Zoledronate in Patients With Early Stage Breast Cancer (REaCT-ZOL)
Clinical trial NCT03664687 · COMPLETED
Trial details
- NCT number
- NCT03664687
- Sponsor
- Ottawa Hospital Research Institute
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-31
- Primary completion
- 2020-04-02
- Enrollment
- 211
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.